U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C18H17ClN2O.ClH
Molecular Weight 349.254
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLAZOLAM HYDROCHLORIDE

SMILES

Cl.CN1C2=CC=C(Cl)C=C2C3N(CCC4=C3C=CC=C4)CC1=O

InChI

InChIKey=QUKBWEQECNCFCF-UHFFFAOYSA-N
InChI=1S/C18H17ClN2O.ClH/c1-20-16-7-6-13(19)10-15(16)18-14-5-3-2-4-12(14)8-9-21(18)11-17(20)22;/h2-7,10,18H,8-9,11H2,1H3;1H

HIDE SMILES / InChI

Molecular Formula C18H17ClN2O
Molecular Weight 312.793
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Clazolam (isoquinazepon) is a fuzed benzodiazepine drug developed by Sandoz in the 1960s. The drug is claimed to have anxiolytic properties, which are manifested in a reduction of cramping, antagonism of amphetamine, and by inhibition of spinal reflexes.

Approval Year

Substance Class Chemical
Record UNII
X1I6TB3OBS
Record Status Validated (UNII)
Record Version